Trademark Overview
On Monday, September 19, 2022, a trademark application was filed for DBV TECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the DBV TECHNOLOGIES trademark a serial number of 79364819. The federal status of this trademark filing is REGISTERED as of Tuesday, May 21, 2024. This trademark is owned by DBV TECHNOLOGIES. The DBV TECHNOLOGIES trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Educational services for consumers and professionals in the field of immunotherapy, namely, organizing classes, seminars, programs, conferences, congresses, workshops in the field of immunotherapy; organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of immunotherapy; publishing periodicals, books, and guides in the field of immunotherapy; database publishing services, namely publishing of periodical journals containing printed databases in tabular form in the field of immunotherapy; providing information with respect to education in the field of immunotherapy via an online website
Medicated adhesive devices in the nature of epicutaneous patches enabling the cutaneous or epicutaneous administration of pharmaceutical or medicated substances in dry form for humans and animals for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases; epicutaneous patches containing powdered preparations for medical use for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases; medicated occlusion patches in the nature of epicutaneous patches enabling the absorption of powdered medicated substances through the skin for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases
Medical services using desensitization methods on the principle of immunotherapy; medical treatment and prevention of allergies, inflammatory, autoimmune and infectious diseases through the administration of allergens, antigens using patches affixed to the patients' unbroken skin, thus avoiding the transfer of allergens into the blood; medical treatment and prevention of allergies, inflammatory, autoimmune and infectious diseases using epicutaneous methods of desensitization via immunotherapy; epicutaneous medical treatments and prevention of allergies, inflammatory, autoimmune and infectious diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to allergies with respect to desensitization to combat allergies
Medical apparatus, instruments and devices, namely, epicutaneous patches sold without medication for the cutaneous or epicutaneous administration of medicated or cosmetic substances in dry form for humans or animals; occlusion patch dispensers for medical use; medical instruments using the electrostatic properties of biocompatible media, namely, epicutaneous patches sold without medication
Medical and scientific research in the field of immunotherapy, namely, developing scientific methods for epicutaneous immunotherapy, to try to treat and prevent autoimmune, infectious and inflammatory diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; scientific research in the field of allergy treatment and care; scientific research in the field of allergy treatment for the repeated application of treatments to patients' skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact and thus avoid the passage of allergens into the blood; allergenic drug discovery services; medical and scientific research services, namely, developing methods for treating allergies via contact between allergens and skin immune cells; medical and scientific research services, namely, developing methods for the treatment and prevention of allergies,...
